Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial.
Cancer Med
; 9(24): 9246-9255, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-33094919
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Fasting
/
Trastuzumab
/
Lapatinib
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Cancer Med
Year:
2020
Type:
Article
Affiliation country:
Japan